In a report released yesterday, Julian Harrison from BTIG maintained a Buy rating on VYNE Therapeutics (VYNE – Research Report), with a price ...

BTIG analyst Ryan Zimmerman maintained a Buy rating on Stryker (SYK – Research Report) yesterday and set a price target of $394.00. The ...

BTIG Research has recently reduced Beyond Air Inc (XAIR) stock to Neutral rating, as announced on June 25, 2024, according to Finviz. Earlier, on July 28, 2023, Piper Sandler had initiated the stock ...

Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $27.67 which represents a slight increase of $0.77 or 2.86% from the prior close of $26.9. The stock opened at $27.68 and ...

Fintel reports that on January 7, 2025, BTIG initiated coverage of Hims & Hers Health (NYSE:HIMS) with a Buy recommendation.

BTIG analyst Thomas Shrader lowered the firm’s price target on Denali Therapeutics (DNLI) to $32 from $35 and keeps a Buy rating on the shares after the company announced topline data from the Phase 2 ...

Deutsche Bank downgraded Adobe (ADBE) to Hold from Buy with a price target of $475, down from $600. The firm believes Adobe ...

Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Get Free Report) has earned a consensus recommendation of “Hold” from the twenty ...

Director Kaufman 2012 Descendants Trust sold 7,500 shares of the stock in a transaction dated Thursday, January 2nd. The ...

Shares of Boston Scientific Corporation (NYSE:BSX) climbed 4.6% following the announcement that the company has agreed to acquire Bolt Medical (TASE:PMCN), a developer of an innovative laser-based ...

Ten-year Treasury yields were hovering just shy of their highest since last May, and the 30-year yield was close to its ...

After fast-food chains tried to win over inflation-weary customers with discounts last year, McDonald’s Corp. kicked off 2025 with yet another deal, launching its new “McValue” menu intended to offer ...